Amyloid PET: Seeing Alzheimer's Plaques in a Living Brain
Amyloid PET shows the amyloid plaques of Alzheimer's in a living brain. Who it helps, what the visit involves, what positive and negative results mean.
Prepared with AI assistance and checked against the linked sources. The update date records an editorial revision; it does not certify physician review.
- → Amyloid PET is a brain scan that lights up amyloid plaques — a hallmark change of Alzheimer's disease — in a living brain.
- → It helps when the diagnosis is uncertain, or when Alzheimer's biology must be confirmed — for example, before infusion treatment.
- → The visit is simple: a tracer injection, a wait of about an hour, and a scan of about 20 minutes.
- → A positive scan supports Alzheimer's pathology; a negative scan makes Alzheimer's unlikely — but neither result alone is a diagnosis.
- → Coverage has changed over time and varies by plan; the clinic verifies it before ordering.
Frank, 70, had memory problems that did not fit a neat pattern. His memory test showed change, his MRI showed no tumor or stroke, and his doctor was still unsure whether Alzheimer's was the cause. His daughter asked the question many families ask: "Can anyone actually see what's happening in his brain?" The answer, in this case, was an amyloid PET scan. It showed amyloid plaques — and with that piece, the diagnosis became clear enough to plan around.
This page explains what amyloid PET does, what the visit feels like, and what the result can — and cannot — tell you.
What it shows
Alzheimer's disease involves clumps of a protein called amyloid that build up between brain cells. These clumps are called plaques. For decades, plaques could only be seen after death, under a microscope. Amyloid PET changed that.
The scan uses a small amount of a radioactive tracer — a substance that sticks to amyloid plaques. A camera then photographs where the tracer has collected. Areas with plaques light up; areas without them do not. A specialist reader judges the pattern and reports the scan as positive (plaques present) or negative (plaques absent).
Two things this scan is not: it is not a memory test, and it is not a staging tool. It does not measure how advanced dementia is, and it does not predict how fast memory may change. It answers one question — is Alzheimer's amyloid biology present? — and that answer helps doctors interpret everything else.
The visit
- Arrival and injection. You arrive at the imaging center, change if asked, and receive the tracer through a small vein injection. The amount of radioactivity is small.
- Waiting. You rest quietly for about an hour while the tracer reaches the brain. Bring a book; a companion may wait with you.
- The scan. You lie still on a table that slides into a scanner, much like a CT machine. The scan itself takes about 20 minutes. It is painless and quiet compared with an MRI.
- Afterwards. You go home the same day. No recovery time is needed. Staff advise on any brief precautions, which are minimal at these doses.
Preparation is usually simple — standard instructions from the imaging center, and a review of medicines and allergies. Tell staff if you are pregnant, breastfeeding, or have trouble lying still, so they can plan with you.
What a positive or negative result means
Positive. Amyloid plaques are present. This supports Alzheimer's pathology as part of the picture. It does not by itself mean dementia — amyloid can be present before symptoms appear, and some people with plaques never develop dementia symptoms. The doctor combines the scan with memory testing, examination, and history before naming a diagnosis.
Negative. Amyloid plaques are essentially absent. This makes Alzheimer's an unlikely explanation for the symptoms, and the doctor usually redirects the search — toward vascular disease, Lewy body disease, sleep problems, mood, medicines, or other causes.
Unclear or borderline. Occasionally a scan sits near the boundary. In that case the doctor may lean on other tests — a blood biomarker such as p-tau217, or spinal-fluid testing — rather than treating one borderline result as final.
Cost and coverage
Amyloid PET is expensive, and coverage has changed over time. Some plans cover it for specific situations — such as uncertain diagnosis or treatment decisions — and some do not. Trial programs sometimes offer it at no cost to participants.
This page deliberately does not quote a price: prices and coverage rules change, and a number printed here could be wrong by the time you read it. The practical step is simple — ask the clinic to verify coverage for your plan before the scan is booked, and ask what alternatives exist (blood biomarker testing or spinal-fluid testing) if coverage is not available.
For clinicians
Amyloid PET tracers (florbetapir, flutemetamol, florbetaben) show high sensitivity and specificity for moderate-to-frequent neuritic plaque burden against neuropathology in validation studies, with visual reads as the standard interpretation method. It is a binary rule-in/rule-out test for Alzheimer's pathology, not a staging or progression marker, and it does not distinguish Alzheimer's dementia from preclinical amyloid positivity — clinical correlation is mandatory. Appropriate-use guidance reserves it for cases where diagnosis remains uncertain after examination, cognitive testing, and MRI, or where amyloid confirmation is required for treatment decisions. Radiation exposure is low (comparable to a CT scan); tracer reactions are rare.
References.
- Jack CR Jr, et al. Revised criteria for diagnosis and staging of Alzheimer's disease (NIA-AA). Alzheimer's & Dementia. 2024.
- Johnson KA, et al. Appropriate use criteria for amyloid PET. Alzheimer's & Dementia. 2013.
- Clark CM, et al. Use of florbetapir-PET for imaging amyloid pathology. JAMA. 2011.
Frequently asked questions
Does a positive scan mean I have dementia?
No. It means amyloid plaques are present. Dementia is diagnosed from symptoms and daily-life impact, not from a scan alone. Amyloid can be present before symptoms appear.
Does it hurt?
No. The only discomfort is usually the small injection for the tracer. The scan itself is painless.
How long do results take?
Usually a few days. Results are discussed at a follow-up visit, with the rest of the workup, rather than delivered alone.
Does insurance cover it?
Coverage varies and has changed over time. The clinic verifies your plan's rules before booking, and can discuss alternatives such as blood biomarker testing if coverage is not available.
How is this different from an MRI?
MRI shows brain structure — shrinkage, strokes, tumors. Amyloid PET shows amyloid biology — whether plaques are present. The two answer different questions and are often used together.
Is the radiation dangerous?
The dose is low, similar to a CT scan. The benefit — a clearer diagnosis that guides treatment and planning — usually outweighs the small risk when the test is medically indicated.
Takeaways
- Amyloid PET shows whether Alzheimer's plaques are present in a living brain — a powerful answer to one specific question.
- Positive supports Alzheimer's pathology; negative makes it unlikely — but diagnosis still needs the clinical picture.
- Coverage varies and changes; verify it with the clinic before booking, and ask about blood or spinal-fluid alternatives.
This article is for education only and is not medical advice. If memory or thinking changes are affecting daily life, book a memory assessment. For sudden confusion, weakness, or rapid change, seek urgent care; call 911 for emergencies.
Book a memory assessment — if an uncertain diagnosis is holding up decisions, ask whether amyloid confirmation would help.
Related reading
Article written by